2,2,3,3-TETRAMETHYL-4,7,10,13-TETRAOXA-3-SILAPENTADECAN-15-OL, 95.0%, 1g

1-[(2-chlorophenyl)methyl]-1,4-diazepane, 95.0%, 250mg

Ethyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside, 97%, 10g

Methyl (2S,4R)-4-fluoropyrrolidine-2-carboxylate, 98%, 250mg

1-BROMOMETHYL-4-ISOPROPYLBENZENE, 95%, 10g

2-Bromo-5-iodotoluene, 98.0%, 100g

N,N'-Diisopropylethylenediamine, 98%, 25g

Doxazosin Mesylate>98.0%(HPLC)(N)100mg

(2E)-4-(Dimethylamino)but-2-enoic acid hydrochloride, 98.0%, 100g

2-(4-Bromopyrazol-1-yl)ethanol, 95.0%, 1g

4-((4-Ethylphenyl)ethynyl)-1,2-difluorobenzene, 95.0%, 25g

4-(benzyloxy)-5-methoxy-2-nitrobenzaldehyde, 95.0%, 5g

Mezcla de ésteres metílicos de ácidos grasos, ROTICHROM® ME 18, 100 mg, envase de plástico.